ARANESP
- Product NDC
- 55513-110
- 11-digit product format
- 555130110
- Labeler code
- 55513
- Product ID
- 55513-110_427e99b1-1e75-4e98-b61e-73f3ba905307
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- darbepoetin alfa
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Amgen Inc
- Application
- BLA103951
- Marketing category
- BLA
- Marketing start
- 2006-08-14
- Marketing end
- 0000-00-00
- Substance
- DARBEPOETIN ALFA
- Active strength
- 300 ug/mL
- Pharmacologic classes
- Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55513-110-01 | 55513011001 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-110-01) > 1 mL in 1 VIAL, SINGLE-DOSE | 2006-08-14 | 0000-00-00 | No | No | Current |